CROWN ADVISORS MANAGEMENT, INC. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
CROWN ADVISORS MANAGEMENT, INC. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$462
-41.9%
150,0000.0%0.34%
-52.3%
Q4 2022$795
-99.8%
150,0000.0%0.72%
+37.9%
Q3 2022$529,000150,0000.52%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders